ABSTRACT
Somatic cell nuclear transfer (SCNT) has a broad spectrum of potential applications, including rescue of endangered species, production of transgenic animals, drug production, and regenerative medicine. Unfortunately, the efficiency of SCNT is still disappointingly low. Many factors affecting cloning procedures have been described in several previous reviews; here we review the most effective improvements in SCNT, with a special emphasis on the effect of mitochondrial defects on SCNT embryo/ foetus development, an issue never touched upon before.
Subject(s)
Nuclear Transfer Techniques/trends , Animals , Animals, Genetically Modified , Ascorbic Acid/metabolism , Ascorbic Acid/pharmacology , Cellular Reprogramming/drug effects , Cloning, Organism , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Histone Deacetylase Inhibitors/pharmacology , Histone Demethylases/metabolism , Mitochondria/genetics , Mitochondria/metabolism , Nuclear Transfer Techniques/adverse effects , Protamines/metabolism , Regenerative Medicine , X Chromosome Inactivation/geneticsSubject(s)
Cell Culture Techniques/methods , Germ Cells/cytology , Inventions/trends , Reproductive Medicine/methods , Biopsy , Female , Germ Cells/pathology , Germ Cells/physiology , Humans , In Vitro Oocyte Maturation Techniques/methods , In Vitro Oocyte Maturation Techniques/trends , Male , Nuclear Transfer Techniques/trends , Reproductive Techniques, Assisted/trends , Semen Analysis/methods , Semen Analysis/trendsABSTRACT
Somatic cell nuclear transfer (SCNT) provides a unique opportunity to directly produce a cloned animal from a donor cell, and it requires the use of skillful techniques. Additionally, the efficiencies of cloning have remained low since the successful production of cloned animals, especially mice. There have been many attempts to improve the cloning efficiency, and trichostatin A (TSA), a histone deacetylase inhibitor, has been widely used to enhance the efficiency of cloning. Here, we report a dramatically improved cloning method in mice. This somatic cell nuclear transfer method involves usage of Hemagglutinating virus of Japan Envelope (HVJ-E), which enables easy manipulation. Moreover, the treatment using two small molecules, TSA and vitamin C (VC), with deionized bovine serum albumin (dBSA), is highly effective for embryonic development. This approach requires neither additional injection nor genetic manipulation, and thus presents a simple, suitable method for practical use. This method could become a technically feasible approach for researchers to produce genetically modified animals from cultured cells. Furthermore, it might be a useful way for the rescue of endangered animals via cloning.
Subject(s)
Ascorbic Acid/therapeutic use , Cloning, Organism/methods , Hydroxamic Acids/therapeutic use , Nuclear Transfer Techniques/trends , Animals , Ascorbic Acid/pharmacology , Embryonic Development/drug effects , Female , Hydroxamic Acids/pharmacology , Male , Mice , PregnancyABSTRACT
Dog cloning as a concept is no longer infeasible. Starting with Snuppy, the first cloned dog in the world, somatic cell nuclear transfer (SCNT) has been continuously developed and used for diverse purposes. In this article we summarise the current method for SCNT, the normality of cloned dogs and the application of dog cloning not only for personal reasons, but also for public purposes.
Subject(s)
Cloning, Organism , Dogs , Nuclear Transfer Techniques/veterinary , Animals , Cloning, Organism/methods , Cloning, Organism/trends , Cloning, Organism/veterinary , Dogs/embryology , Embryo Transfer/veterinary , Embryo, Mammalian , Nuclear Transfer Techniques/trendsABSTRACT
Interest in equine somatic cell nuclear transfer technology has increased significantly since the first equid clones were produced in 2003. This is demonstrated by the multiple commercial equine cloning companies having produced numerous cloned equids to date; worldwide, more than 370 cloned horses have been produced in at least six different countries. Equine cloning can be performed using several different approaches, each with different rates of success. In this review we cover the history and applications of equine cloning and summarise the major scientific advances in the development of this technology in horses. We explain the advantages and disadvantages of different procedures to produce cloned equine embryos and describe the current status of equine clone commercialisation, along with observations of differences in regional breed association registration regulations.
Subject(s)
Cloning, Organism , Horses , Nuclear Transfer Techniques/veterinary , Animals , Cloning, Organism/history , Cloning, Organism/methods , Cloning, Organism/veterinary , Embryo, Mammalian , History, 21st Century , Horses/embryology , Nuclear Transfer Techniques/history , Nuclear Transfer Techniques/trendsABSTRACT
Initial nuclear transplantation experiments in Xenopus eggs provided the first evidence for the conservation of the genome after cellular differentiation. This Discovery-in-Context Review recounts the early experiments that led to successful nuclear transfer in amphibians and the establishment of totipotency of a differentiated cell and shows how these discoveries paved the way for similar cloning experiments in other organisms.
Subject(s)
Cell Nucleus/genetics , Cloning, Organism/methods , Genome , Nuclear Transfer Techniques/trends , Animals , Cattle , Cell Differentiation , Cloning, Organism/history , Genomic Instability , History, 20th Century , History, 21st Century , Mice , Nuclear Transfer Techniques/history , Oocytes/cytology , Oocytes/metabolism , Sheep , Swine , Xenopus laevis/geneticsABSTRACT
To commemorate Transgenic Animal Research Conference X, this review summarizes the recent progress in developing genetically engineered livestock species as biomedical models. The first of these conferences was held in 1997, which turned out to be a watershed year for the field, with two significant events occurring. One was the publication of the first transgenic livestock animal disease model, a pig with retinitis pigmentosa. Before that, the use of livestock species in biomedical research had been limited to wild-type animals or disease models that had been induced or were naturally occurring. The second event was the report of Dolly, a cloned sheep produced by somatic cell nuclear transfer. Cloning subsequently became an essential part of the process for most of the models developed in the last 18 years and is stilled used prominently today. This review is intended to highlight the biomedical modeling achievements that followed those key events, many of which were first reported at one of the previous nine Transgenic Animal Research Conferences. Also discussed are the practical challenges of utilizing livestock disease models now that the technical hurdles of model development have been largely overcome.
Subject(s)
Animals, Genetically Modified/genetics , Cloning, Organism/trends , Genetic Engineering/trends , Livestock/genetics , Animals , Biomedical Research/trends , Disease Models, Animal , Nuclear Transfer Techniques/trends , Sheep/genetics , Swine/geneticsABSTRACT
At the time of the first Transgenic Animal Research Conference, the lack of knowledge about promoter, enhancer and coding regions of genes of interest greatly hampered our efforts to create transgenes that would express appropriately in livestock. Additionally, we were limited to gene insertion by pronuclear microinjection. As predicted then, widespread genome sequencing efforts and technological advancements have profoundly altered what we can do. There have been many developments in technology to create transgenic animals since we first met at Granlibakken in 1997, including the advent of somatic cell nuclear transfer-based cloning and gene editing. We can now create new transgenes that will express when and where we want and can target precisely in the genome where we want to make a change or insert a transgene. With the large number of sequenced genomes, we have unprecedented access to sequence information including, control regions, coding regions, and known allelic variants. These technological developments have ushered in new and renewed enthusiasm for the production of transgenic animals among scientists and animal agriculturalists around the world, both for the production of more relevant biomedical research models as well as for agricultural applications. However, even though great advancements have been made in our ability to control gene expression and target genetic changes in our animals, there still are no genetically engineered animal products on the market for food. World-wide there has been a failure of the regulatory processes to effectively move forward. Estimates suggest the world will need to increase our current food production 70 % by 2050; that is we will have to produce the total amount of food each year that has been consumed by mankind over the past 500 years. The combination of transgenic animal technology and gene editing will become increasingly more important tools to help feed the world. However, to date the practical benefits of these technologies have not yet reached consumers in any country and in the absence of predictable, science-based regulatory programs it is unlikely that the benefits will be realized in the short to medium term.
Subject(s)
Animals, Genetically Modified/genetics , Cloning, Organism/trends , Genetic Engineering/trends , Livestock/genetics , Agriculture , Animals , Animals, Genetically Modified/growth & development , Genome , Livestock/growth & development , Nuclear Transfer Techniques/trendsABSTRACT
Nuclear transfer that involves the transfer of the nucleus from a donor cell into an oocyte or early embryo from which the chromosomes have been removed was considered first as a means of assessing changes during development in the ability of the nucleus to control development. In mammals, development of embryos produced by nuclear transfer depends upon coordination of the cell cycles of donor and recipient cells. Our analysis of nuclear potential was completed in 1996 when a nucleus from an adult ewe mammary gland cell controlled development to term of Dolly the sheep. The new procedure has been used to target the first precise genetic modification into livestock; however, the greatest inheritance of the Dolly experiment was to make biologists think differently. If unknown factors in the recipient oocyte could reprogramme the nucleus to a stage very early in development then there must be other ways of making that change. Within 10 years, two laboratories working independently established protocols by which the introduction of selected transcription factors changes a small proportion of the treated cells to pluripotent stem cells. This ability to produce 'induced pluripotent stem cells' is providing revolutionary new opportunities in research and cell therapy.
Subject(s)
Cloning, Organism/methods , Nuclear Transfer Techniques , Amphibians , Animals , Cellular Reprogramming Techniques , Cloning, Organism/trends , Female , Humans , Induced Pluripotent Stem Cells/cytology , Mammals , Nuclear Transfer Techniques/trends , Primates , Sheep, DomesticABSTRACT
Nuclear transfer has seen a remarkable comeback in the past few years. Three groups have independently reported the derivation of stem cell lines by somatic cell nuclear transfer, from either adult, neonatal or fetal cells. Though the ability of human oocytes to reprogram somatic cells to stem cells had long been anticipated, success did not arrive on a straightforward path. Little was known about human oocyte biology, and nuclear transfer protocols developed in animals required key changes to become effective with human eggs. By overcoming these challenges, human nuclear transfer research has contributed to a greater understanding of oocyte biology, provided a point of reference for the comparison of induced pluripotent stem cells, and delivered a method for the generation of personalized stem cells with therapeutic potential.
Subject(s)
Cellular Reprogramming/genetics , Nuclear Transfer Techniques/trends , Oocytes/growth & development , Pluripotent Stem Cells/metabolism , Animals , Cell Nucleus/genetics , Embryonic Stem Cells/metabolism , Humans , Oocytes/metabolism , Precision MedicineABSTRACT
The exchange of nuclear genetic material between oocytes and embryos offers a novel reproductive option for the prevention of inherited mitochondrial diseases. Mitochondrial dysfunction has been recognized as a significant cause of a number of serious multiorgan diseases. Tissues with a high metabolic demand, such as brain, heart, muscle, and central nervous system, are often affected. Mitochondrial disease can be due to mutations in mitochondrial DNA or in nuclear genes involved in mitochondrial function. There is no curative treatment for patients with mitochondrial disease. Given the lack of treatments and the limitations of prenatal and preimplantation diagnosis, attention has focused on prevention of transmission of mitochondrial disease through germline gene replacement therapy. Because mitochondrial DNA is strictly maternally inherited, two approaches have been proposed. In the first, the nuclear genome from the pronuclear stage zygote of an affected woman is transferred to an enucleated donor zygote. A second technique involves transfer of the metaphase II spindle from the unfertilized oocyte of an affected woman to an enucleated donor oocyte. Our group recently reported successful spindle transfer between human oocytes, resulting in blastocyst development and embryonic stem cell derivation, with very low levels of heteroplasmy. In this review we summarize these novel assisted reproductive techniques and their use to prevent transmission of mitochondrial disorders. The promises and challenges are discussed, focusing on their potential clinical application.
Subject(s)
Fertilization in Vitro/methods , Genetic Therapy/methods , Mitochondrial Diseases/genetics , Mitochondrial Diseases/prevention & control , Animals , Female , Fertilization in Vitro/trends , Genetic Therapy/trends , Humans , Male , Nuclear Transfer Techniques/trends , Reproductive Techniques, Assisted/trendsABSTRACT
No disponible
Subject(s)
Humans , Male , Female , Biological Therapy/ethics , Biological Therapy/methods , Germ Cells , Mitochondrial Diseases/epidemiology , Mitochondrial Diseases/therapy , Nuclear Transfer Techniques/ethics , Nuclear Transfer Techniques/legislation & jurisprudence , Nuclear Transfer Techniques/trends , Nuclear Transfer TechniquesSubject(s)
Cloning, Organism/ethics , Cloning, Organism/trends , Cloning, Organism/psychology , Female , Humans , In Vitro Oocyte Maturation Techniques/ethics , In Vitro Oocyte Maturation Techniques/trends , Induced Pluripotent Stem Cells/cytology , Nuclear Transfer Techniques/ethics , Nuclear Transfer Techniques/trends , Oocyte Donation , Publishing/ethics , Publishing/trends , Research Embryo CreationABSTRACT
Bovine somatic cell nuclear transfer (SCNT) embryos can develop to the blastocyst stage at a rate similar to that of embryos produced by in vitro fertilization. However, the full-term developmental rate of SCNT embryos is very low, owing to the high embryonic and fetal losses after embryo transfer. In addition, increased birth weight and postnatal mortality are observed at high rates in cloned calves. The low efficiency of SCNT is probably attributed to incomplete reprogramming of the donor nucleus and most of the developmental problems of clones are thought to be caused by epigenetic defects. Applications of SCNT will depend on improvement in the efficiency of production of healthy cloned calves. In this review, we discuss problems and recent progress in bovine SCNT.
Subject(s)
Cattle/physiology , Nuclear Transfer Techniques/trends , Animals , Birth Weight , Clone Cells , DNA Methylation/drug effects , Efficiency , Epigenesis, Genetic/drug effects , Female , Histone Deacetylase Inhibitors/pharmacology , Male , Oocytes/physiology , Tissue DonorsABSTRACT
After the development of induced pluripotent stem cells (IPSCs) in 2007, the pressure to commercialize women's eggs for stem cell research could have been expected to lessen. However, the pressure to harvest human eggs in large quantities for research has not diminished; rather, it has taken different directions, for example in germline mitochondrial research. Yet there has been little acknowledgement of these technologies' need for human eggs, the possible risks to women and the ethical issues concerning potential exploitation. Rather, there has been a renewed campaign to legalize payment for eggs in research, although the actual scientific advances are at best modest. This article shows why a market in women's eggs is ethically problematic in terms of the doctor's duty to do no harm and the limitations of 'informed' consent.
Subject(s)
Commodification , Embryo Research/ethics , Informed Consent , Mitochondria , Nuclear Transfer Techniques/ethics , Ovum , Reimbursement Mechanisms , Tissue Donors , Female , Humans , Korea , Mitochondria/transplantation , Nuclear Transfer Techniques/trends , Stem Cells , United StatesABSTRACT
It has been 30 years since the first transgenic mouse was generated and 26 years since the first example of transferring the technology to livestock was published. While there was tremendous optimism in those initial years, with most convinced that genetically modified animals would play a significant role in agricultural production, that has not come to be. So at first sight one could conclude that this technology has, to a large extent, failed. On the contrary, it is believed that it has succeeded beyond our original expectations, and we are now at what is perhaps the most exciting time in the development and implementation of these technologies. The original goals, however, have drastically changed and it is now biomedical applications that are playing a central role in pushing both technical and scientific developments. The combination of advances in somatic cell nuclear transfer, the development of induced pluripotent stem cells and the completion of the sequencing of most livestock genomes ensures a bright and exciting future for this field, not only in livestock but also in companion animal species.
Subject(s)
Agriculture/trends , Animals, Genetically Modified , Biomedical Technology/trends , Animals , Animals, Domestic , Nuclear Transfer Techniques/trends , Nuclear Transfer Techniques/veterinary , Pluripotent Stem Cells , Stem Cell ResearchABSTRACT
In this brief review, I have highlighted recent advances in several areas of mitochondrial medicine, including mtDNA-related diseases, mendelian mitochondrial encephalomyopathies, and therapy. The pathogenic mechanisms of mtDNA mutations, especially those affecting mitochondrial protein synthesis, are still largely unknown. The pathogenicity of homoplasmic mtDNA mutations has become evident but has also called attention to modifying nuclear genes, yet another example of impaired intergenomic signaling. The functional significance of the homoplasmic changes associated with mitochondrial haplogroups has been confirmed. Among the mendelian disorders, a new form of "indirect hit" has been described, in which the ultimate pathogenesis is toxic damage to the respiratory chain. Three therapeutic strategies look promising: (i) allogeneic hematopoietic stem cell transplantation in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy); (ii) bezafibrate, an activator of PGC-1alpha, has proven effective in animal models of mitochondrial myopathy; and (iii) pronucleus transfer into a normal oocyte is effective in eliminating maternal transmission of mtDNA, thus preventing the appearance of mtDNA-related disorders.
Subject(s)
Mitochondrial Myopathies/etiology , Mitochondrial Myopathies/therapy , Animals , Bezafibrate/therapeutic use , DNA, Mitochondrial/genetics , Disease Models, Animal , Hematopoietic Stem Cell Transplantation/trends , Humans , Mutation/genetics , Nuclear Transfer Techniques/trendsABSTRACT
Nuclear transfer (NT) is a new cloning technology developed in recent years. NT methods consist of electrofusion, NT mediated by polyethylene glycol (PEG) and microinjection. The success of somatic nuclear transfer depends on the source of donor nucleus, developmental stage of recipient cytoplasts, cell cycle synchrony of donor nucleus. Different methods of harvesting cells have effect on the efficiency of NT. The somatic nucleus will be reprogrammed after NT and will restore a totipotent state in order to undergo development.